We are live on ! Find out more
ABEO icon

Abeona Therapeutics

100 hedge funds and large institutions have $188M invested in Abeona Therapeutics in 2025 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more call options, than puts

Call options by funds: $8.67M | Put options by funds: $2.06M

58% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 24

36% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 14

5% more funds holding

Funds holding: 95100 (+5)

1.17% more ownership

Funds ownership: 68.23%69.4% (+1.2%)

5% less capital invested

Capital invested by funds: $198M → $188M (-$10.3M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
100
Holders Change
+5
Holders Change %
+5.26%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
19
Increased
38
Reduced
24
Closed
14
Calls
$8.67M
Puts
$2.06M
Net Calls
+$6.62M
Net Calls Change
-$5.63M
Name Holding Trade Value Shares
Change
Change in
Stake
AIP
76
Ameritas Investment Partners
Nebraska
$23.5K
TC
77
Truvestments Capital
Florida
$18.7K +$4.93K +778 +28%
California State Teachers Retirement System (CalSTRS)
78
California State Teachers Retirement System (CalSTRS)
California
$14.4K +$13 +2 +0.1%
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$14K -$28.6K -4,508 -64%
New York State Common Retirement Fund
80
New York State Common Retirement Fund
New York
$8.88K -$97K -15,300 -90%
MCM
81
MAI Capital Management
Ohio
$8.55K
AB
82
Amalgamated Bank
New York
$8K
SS
83
Sunbelt Securities
Texas
$7.92K +$9.51K +1,500 New
Rockefeller Capital Management
84
Rockefeller Capital Management
New York
$6.6K +$7.93K +1,250 New
Osaic Holdings
85
Osaic Holdings
Arizona
$6.21K -$6.04K -952 -50%
Jones Financial Companies
86
Jones Financial Companies
Missouri
$5.44K
FFA
87
Farther Finance Advisors
California
$3.82K +$2.17K +343 +90%
S
88
SignatureFD
Georgia
$3.63K +$3.25K +512 +293%
QCG
89
Quadrant Capital Group
Ohio
$3.52K +$4.23K +667 New
PNC Financial Services Group
90
PNC Financial Services Group
Pennsylvania
$2.54K +$3.06K +482 New
PA
91
Parallel Advisors
California
$2.11K
VWWMG
92
Vermillion & White Wealth Management Group
Pennsylvania
$1.95K
AAP
93
Arax Advisory Partners
Colorado
$1.47K +$1.77K +279 New
SCM
94
Sterling Capital Management
North Carolina
$1.36K +$609 +96 +59%
NA
95
NewEdge Advisors
Louisiana
$1.19K +$1.43K +225 +22,500%
SS
96
SBI Securities
Japan
$1.03K +$209 +33 +20%
MPWT
97
MassMutual Private Wealth & Trust
Connecticut
$665 +$799 +126 New
GI
98
GAMMA Investing
California
$253 +$304 +48 New
DWM
99
Darwin Wealth Management
Florida
$137
LCM
100
Laurion Capital Management
New York
-$1.57M -275,915 Closed

ABEO Hedge Fund Activity: Q3 2025 in Review

100 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2025, worth a combined $188M — down 5.2% from $198M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ABEO positions and 14 closed out — a net gain of 5 holders — while 38 added to existing stakes and 24 trimmed.

The largest buyer was Cable Car Capital, opening a new position worth an estimated $3.81M. The largest seller was Western Standard LLC, cutting an estimated $5.34M.

  • 100 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2025, up from 95 in Q2 2025.
  • Funds reported $188M of Abeona Therapeutics stock for Q3 2025, down 5.2% quarter-over-quarter.
  • 19 funds opened new Abeona Therapeutics positions in Q3 2025 and 14 closed out, a net change of +5 holders.
  • The largest Abeona Therapeutics buyer in Q3 2025 was Cable Car Capital, an estimated $3.81M added.
  • The largest Abeona Therapeutics seller in Q3 2025 was Western Standard LLC, an estimated $5.34M sold.

Based on aggregated 13F filings for Q3 2025.